LP
WST icon

Longview Partners’s West Pharmaceutical WST Stock Holding History

Longview Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$371M Sell
1,033,826
-281,577
-21% -$86.1M 6.03% 1
2026
Q1 		$330M Buy
1,315,403
+184,377
+16% +$45.9M 4.67% 1
2025
Q4 		$311M Buy
1,131,026
+778,887
+221% +$213M 3.25% 22
2025
Q3 		$92.4M Buy
+352,139
New +$85.6M 0.97% 23

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Longview Partners's WST Position: Q2 2026 in Review

Longview Partners reduced its West Pharmaceutical (WST) stake by 21% in Q2 2026, selling an estimated $86.1M and leaving 1,033,826 shares worth $371M. The position accounts for 6.03% of the portfolio, ranked #1.

Longview Partners first reported a position in WST in Q3 2025 and has held it in 4 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Longview Partners held 1,033,826 shares of West Pharmaceutical worth $371M as of Q2 2026.
  • Longview Partners sold 281,577 West Pharmaceutical shares in Q2 2026, an estimated $86.1M.
  • West Pharmaceutical made up 6.03% of Longview Partners's portfolio in Q2 2026, its #1 holding.
  • Longview Partners first reported a position in West Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Longview Partners's 13F filing for Q2 2026, filed 13 Aug 2026.